Best Treatment for Meibomian Gland Dysfunction- Azithromycin
Best Treatment for Meibomian Gland Dysfunction - Azithromycine
New Research Indicates Azithromycin is more effective than Doxycycline for Meibomian Gland Dysfunction and Blepharitis.
There are several studies concerning the use of topical azithromycin in ocular surface diseases.
New
research at the University of Louisville compared the effectiveness of
topical azithromycin versus oral doxycycline therapy in meibomian gland
dysfunction (and Blepharitis) Twenty-two (22) subjects were treated
with topical azithromucin solution for one month and seven subjects were
treated with oral doxycycline for two (20 months. The study concluded
that while both topical azithromycin and oral doxycycline improved
clinical signs and symptoms of meibomian gland dysfunction, the
"response to azithromycin is more rapid and more robust than
doxycycline."
Another
research study from the Ohio State University evaluated the efficacy of
a four-week treatment with topical 1.0% azithromycin solution versus
rewetting drops in patients with contact lens related dry eye. Patients
are able to wear contact lenses two-hours longer throughout the
four-week study period when azithromycin solution was use.
Blepharitis
being a chronic inflammation of the eye lid goes hand in hand with
Meibomian Gland Dysfunction and chronic dry eyes. Here is how TheraLife
Eye can help!
How can TheraLife Eye Help?
TheraLife
Eye is uniquely formulated to restore normal cell functions to tear
secretion glands intra-cellularly for sustainable, long lasting relief.
Clinically proven to work for 80% of first time users. Antibiotics help
reduce inflammation, however, inflammation shuts down tear secretion
glands. Use TheraLife Eye to restore normal tear function.
best treatment for Meibomian Gland Dysfuncton MGD- Azithromycin. Learn more from TheraLife.
ReplyDelete